|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 14-12-09 | Cubist Pharmaceuticals : sales force seen as potential boon for Merck intestinal drug | RE |
| 14-12-09 | Cubist Pharmaceuticals : Merck says still plans to buy Cubist, despite patent setback | RE |
Stock exchange
Nasdaq- $
-
0
$
| Markets | Price | Change | Volumes |
|---|
Basic data
Market Cap (USD)
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 0 | ||
| -1.87% | +4.22% | +44.36% | +1.14% | 82.65B | ||
| +0.41% | +2.05% | -17.95% | -34.72% | 60.24B | ||
| -2.23% | +5.48% | +478.96% | +34.47% | 58.11B | ||
| -2.03% | -2.62% | -8.63% | +29.27% | 49.68B | ||
| -4.58% | -2.73% | +1.79% | +155.89% | 46.66B | ||
| -1.64% | +1.07% | +56.98% | -16.26% | 32.63B | ||
| -0.98% | +1.91% | +46.30% | +100.59% | 25.69B | ||
| -0.19% | -4.74% | -0.68% | +195.10% | 22.73B | ||
| -1.13% | -2.45% | +64.66% | +108.82% | 16.54B | ||
| Average | -1.59% | -0.07% | +73.98% | +63.81% | 39.49B | |
| Weighted average by Cap. | -1.72% | +0.81% | +86.53% | +43.10% |
Historical Quotes: Cubist Pharmaceuticals Inc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- Stock
- Quotes Cubist Pharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
















